Amneal Pharmaceuticals, Return On Tangible Assets Over Time
| AMRX Stock | USD 8.39 0.07 0.84% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Amneal Pharmaceuticals, Performance and Amneal Pharmaceuticals, Correlation. Amneal |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amneal Pharmaceuticals,. If investors know Amneal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amneal Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.75) | Earnings Share (0.86) | Revenue Per Share 9.16 | Quarterly Revenue Growth 0.133 | Return On Assets 0.0594 |
The market value of Amneal Pharmaceuticals, is measured differently than its book value, which is the value of Amneal that is recorded on the company's balance sheet. Investors also form their own opinion of Amneal Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is Amneal Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amneal Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect Amneal Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amneal Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Amneal Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amneal Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Return On Tangible Assets Analysis
Compare Amneal Pharmaceuticals, and related stocks such as Capricor Therapeutics, Soleno Therapeutics, and Bio Path Holdings Return On Tangible Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAPR | (0.7067) | (3.5599) | (38.8339) | (2.3519) | (0.5227) | (0.8942) | (1.0108) | 0.1503 | (1.6517) | (0.6642) | (0.3894) | (0.4696) | (0.5793) | (0.3795) | (0.4) |
| SLNO | (2.5782) | (2.5782) | (2.5782) | (2.3365) | (1.6525) | (2.4227) | (2.9943) | (0.8419) | (0.5403) | (1.6591) | (0.3051) | (1.29) | (1.2857) | (0.2268) | (0.24) |
| BPTH | (0.4414) | (2.0485) | (3.3469) | (0.8906) | (0.3177) | (0.5656) | (0.5991) | (0.8682) | (3.6758) | (0.3753) | (0.6589) | (0.3928) | (0.8663) | (4.9932) | (4.74) |
| MBRX | (26.6406) | (26.6406) | (26.6406) | (26.6406) | (26.6406) | (26.6406) | (0.7485) | (1.1764) | (1.4076) | (0.9374) | (0.8386) | (0.1215) | (0.5923) | (1.0997) | (1.15) |
| CRNX | (0.4777) | (0.4777) | (0.4777) | (0.4777) | (0.4777) | (0.4777) | (0.4777) | (0.5871) | (0.1582) | (0.3799) | (0.3972) | (0.304) | (0.4542) | (0.3377) | (0.35) |
| ASMB | (10.0948) | (0.9271) | (1.206) | (0.7152) | (0.8067) | (0.3089) | (0.7837) | (0.3353) | (0.4008) | (0.3273) | (0.2464) | (0.6742) | (0.9045) | (0.4454) | (0.47) |
| TIL | (0.6811) | (0.6811) | (0.6811) | (0.6811) | (0.6811) | (0.6811) | (0.6811) | (0.6811) | (0.6811) | (0.6811) | (0.1245) | (0.2639) | (0.4629) | (0.4793) | (0.5) |
| CTMX | (1.3186) | (1.3186) | (1.3186) | (1.3186) | (0.4308) | (0.1819) | (0.2999) | (0.1091) | (0.1861) | (0.3016) | (0.0922) | (0.239) | (0.3756) | (0.0028) | (0.003) |
| ACHL | (0.4934) | (0.4934) | (0.4934) | (0.4934) | (0.4934) | (0.4934) | (0.4934) | (0.4934) | (0.4934) | (0.133) | (0.1517) | (0.1927) | (0.323) | (0.4315) | (0.45) |
Amneal Pharmaceuticals, and related stocks such as Capricor Therapeutics, Soleno Therapeutics, and Bio Path Holdings Return On Tangible Assets description
A profitability metric that measures a company's ability to generate earnings from its tangible assets.My Equities
My Current Equities and Potential Positions
| Amneal Pharmaceuticals, Class | AMRX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 400 Crossing Boulevard, |
| Exchange | New York Stock Exchange |
USD 8.39
Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.